secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001178670-24-000027
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam shareholders re-elect four Class II directors, approve say-on-pay and auditor
--------------------------------------------------------------------------------

- All four Class II nominees (Ausiello, Brandicourt, Kellogg, Pyott) re-elected with >90% of votes cast.
- Non-binding advisory vote on executive compensation passed: 106.8M for, 6.1M against.
- Ratification of PricewaterhouseCoopers as FY2024 auditor approved: 114.5M for, 3.5M against.
- All proposals passed with substantial margins; total shares outstanding 126,452,099.
- Terms of eight other directors continued after the meeting; no changes to board composition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000117867024000027/0001178670-24-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000117867024000027/alny-20240516.htm
  HTML page:      https://secwatch.observer/filing/0001178670-24-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer